Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-18 Hoitt Jason Chief Patient Officer Sale −1,762 $31.28 $55K 10,445
2026-03-18 Hoitt Jason Chief Patient Officer Sale −139 $31.79 $4K 10,306
2026-03-18 Hoitt Jason Chief Patient Officer Sale −30 $32.85 $986 10,276
2026-03-17 Hoitt Jason Chief Patient Officer Sale −1,033 $32.74 $34K 12,955
2026-03-17 Hoitt Jason Chief Patient Officer Sale −748 $33.38 $25K 12,207
2026-03-15 Hoitt Jason Chief Patient Officer Option exercise +10,000 13,988
2026-03-15 Hoitt Jason Chief Patient Officer Option exercise · Restricted Stock Units −10,000 30,000
2026-02-17 Hoitt Jason Chief Patient Officer Grant or award · Employee Stock Option (Right to Buy) +72,000 72,000
2026-02-17 Hoitt Jason Chief Patient Officer Grant or award · Restricted Stock Units +48,000 48,000

Page 1 of 1 · 9 trades